H Maheswaran, P Barton (2012) Intensive case finding and Isoniazid preventative therapy in HIV infected individuals in sub-Saharan Africa: Economic model and value of information analysis. PLoS ONE 7(1):e30457.
TE Roberts, PM Barton, PE Auguste, LJ Middleton, AT Furmston, AK Ewer (2012) Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis. Archives of Disease in Childhood vol 97 no 3 pp 221-226 DOI: 10.1136/archdischild-2011-300564
P Barton. (2011) Development of the Birmingham Rheumatoid Arthritis Model: Past, Present, and Future Plans. Rheumatology 50:iv32-iv38. DOI: 10.1093/rheumatology/KER244
P Barton, L Andronis, A Briggs, K McPherson, S Capewell (2011) Effectiveness and cost-effectiveness of cardiovascular disease prevention in whole populations: modelling study. British Medical Journal. 2011;343:d4044. DOI: 10.1136/bmj.d4044
S Bhattacharya, LJ Middleton, A Tsourapas, AJ Lee, R Champaneria, JP Daniels, T Roberts, NH Hilken, P Barton, R Gray, KS Khan, P Chien, P O’Donovan, KG Cooper and the International Heavy Menstrual Bleeding IPD Meta-analysis Collaborative Group. (2011) Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of effectiveness and cost effectiveness analysis. Health Technology Assessment. vol. 15, no 19 [pp 1-246] DOI: 10.3310/hta15190
PE Auguste, PM Barton, CJ Hyde, TE Roberts (2011) An economic evalution of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence. Health Technology Assessment, vol 15, no 18 [pp 1-48] DOI: 10.3310/hta15180
P Barton (2011) What happens to value of information measures as the number of decision options increases? Health Economicsvol 20 pp 853-863 DOI: 10.1002/hec.1651
K Malottki, P Barton, A Tsourapas, AO Uthman, Z Liu, K Routh, M Connock, P Jobanputra, D Moore, A Fry-Smith, YF Chen. (2011) Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor: a systematic review and economic evaluation. Health Technology Assessment, vol 15 no 14 [pp 1-271] DOI: 10.3310/hta15140